Press Releases

The Asia Group Serves as Key Strategic and Sales Advisor to Groundbreaking Collaboration Agreement to Bring MRNA Vaccine Technology to Vietnam

FOR IMMEDIATE RELEASE

HANOI, Vietnam; WASHINGTON DC, United States, August 2, 2021 – The Asia Group, LLC (“TAG”), a leading Washington-based strategic advisory firm supporting global businesses and investors across the Indo-Pacific, is proud to announce its efforts as principal strategic and sales advisor to a groundbreaking collaboration and licensed production agreement between Arcturus Therapeutics Holdings Inc. (ARCT) and Vinbiocare Biotechnology Joint Stock Company, a member of Vingroup Joint Stock Company, one of Vietnam’s largest companies for Arcturus’ mRNA vaccine against COVID-19.

As the primary strategic advisor to the agreement, TAG CEO and Co-Founder, Nirav Patel, and Vietnam Country Director Hung Nguyen have once again demonstrated the firm’s unique capabilities and commitment to supporting its clients’ growth in Vietnam and throughout the Indo-Pacific.

Discussing this landmark agreement, Patel noted that “TAG is excited to support our client’s strategic and commercial interests in one of the most dynamic markets in the world and in doing so providing the people of Vietnam with cutting edge vaccines to address the COVID-19 pandemic.”

On working with TAG, Arcturus’ Senior Vice President for Business Development, Kevin Skol said: “We’ve relied on TAG’s strategic guidance and networks as we have explored significant market entry opportunities throughout the Asia-Pacific, they have proven to be a trusted counselor.”

From Vingroup Vice Chair Le Thi Thu Thuy: “The Asia Group team led by Nirav Patel and Hung Nguyen has proven instrumental in supporting critical commercial investments of the technology necessary to support the people of Vietnam and enabling Vingroup and Arcturus’ strategic and commercial partnership. We look forward to continuing to work with the TAG team as we look for new opportunities to expand our business.”

The Asia Group is the premier strategic advisory firm to the world’s leading companies seeking to excel across the Indo-Pacific. With a team of dynamic and experienced professionals – from consultants and former senior government officials to lawyers and investment bankers – The Asia Group supports companies with end-to-end integrated strategies for market entry and expansion, identification of strategic partners, and structuring of M&A efforts, private placements, financing needs, and joint ventures.

Arcturus is a U.S.-based leader in cutting-edge vaccine and medicine development. Its potential single shot mRNA vaccine ARCT-021 is undergoing phase 2 clinical trials in the United States and Singapore, and promising clinical data demonstrates a favorable safety profile and both humoral and cellular immunogenicity against COVID-19. As part of this agreement, Arcturus will work with the Government of Vietnam to develop a phase 3 trial to further demonstrate ARCT-021’s safety profile and efficacy for the Vietnam market.

Vingroup is the largest private enterprise in Vietnam, with a market capitalization exceeding USD 21 billion and USD 4.7 billion in annual sales. Founded in 1993, Vingroup’s operations include a diversified portfolio of investments in real estate, retail, automotive manufacturing, and scientific research. With the mission “To Create a Better Life for the Vietnamese People,” Vingroup’s products and services are known for their quality and adherence to international standards.

Recent Posts

TAG China Country Director Han Lin Joins the BBC to Discuss the U.S.-Vietnam Trade Deal, Mexico Remittances, the U.S. “Big Beautiful Bill” and Other Topics
Han Lin, China Country Director at The Asia Group, told the BBC that while the passage of the “Big Beautiful ...
TAG Managing Partner, Amb. Kurt Tong Spoke with Bloomberg on Japan’s Response to Potential U.S. Punitive Action
TAG Managing Partner, Amb. Kurt Tong spoke with bloomberg where we discussed Japan’s potential response to any upcoming U.S. punitive ...
美商亞洲集團宣布陳澍(George Chen)榮升合夥人
華盛頓特區及香港 | 2025年7月1日 – 美商亞洲集團(The Asia Group)欣然宣布陳澍(George Chen)晉升為集團的合夥人。陳澍將繼續領導集團在香港和台北的辦公室,並擔任TAG數位部門的聯席主席。陳澍的晉升充分展示了美商亞洲集團進一步結合頂尖全球視野與泛區域洞察的實力,也體現集團對印度-太平洋地區運營的重視,以及對客戶提供完整策略性解決方案和服務的堅定承諾。
The Asia Group Announces George Chen as Partner
Washington, DC & Hong Kong | July 1, 2025 – The Asia Group (TAG) is excited to announce the promotion ...
Scroll to Top

You Are Applying For:

The Asia Group Serves as Key Strategic and Sales Advisor to Groundbreaking Collaboration Agreement to Bring MRNA Vaccine Technology to Vietnam

Apply Now

Submit the details below, and our HR team member will get in touch with you shortly.

The Asia Group is an equal opportunity employer where an applicant’s qualifications are considered without regard to race, color, religion, sex, national origin, age, disability, veteran status, genetic information, sexual orientation, gender identity or expression, or any other basis prohibited by law. The Asia Group continually seeks to diversify its staff, particularly to broaden opportunities for individuals from demographic groups that are historically underrepresented in the strategic advisory profession.

"*" indicates required fields

1Personal Details
2Questionnaire & Application Materials
3Voluntary Self Identification

Personal Details

Name*
Address*